Literature DB >> 6125178

Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.

V Hombach, V Braun, H W Höpp, D Gil-Sanchez, D W Behrenbeck, M Tauchert, H H Hilger.   

Abstract

1 In 46 patients (16 female and 30 male), aged between 18 and 73 years and effect of acute beta-adrenoceptor blockade with i.v. pindolol, acebutolol and atenolol has been studied at rest and during ergometric exercise, during routine intracardiac His bundle investigations. 2 At rest the functional parameters of the sinus node were impaired most markedly by atenolol. A-V nodal conduction was more depressed with acebutolol and atenolol than with pindolol. The His-Purkinje system conduction remained unaffected by all three beta-adrenoceptor blocking agents. 3 During ergometric exercise the depressant action of beta-adrenoceptor blockade on sinus nodal function with lower heart rates and on A-V nodal conduction with slower conduction velocities was equieffective with pindolol, acebutolol and atenolol. His-Purkinje system conduction again remained unchanged with one exception that after administration of pindolol, conduction rate during exercise was faster than before beta-adrenoceptor blockade. 4 It may be concluded that, in patients with low heart rates, an antagonist such as pindolol with relatively pronounced intrinsic sympathomimetic activity can be considered to be the drug of choice. In contrast, patients with higher heart rates at rest should be treated with a cardioselective betablocker without ISA. Patients with overt Sick Sinus Syndrome should not be given beta-adrenoceptor blockers at all. 5 Physical activity may change (improve or impair) the antiarrhythmic potency of beta-adrenoceptor blockers used in the treatment of supraventricular tachycardias or tachyarrhythmias.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125178      PMCID: PMC1402148          DOI: 10.1111/j.1365-2125.1982.tb01926.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

Review 1.  Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C.

Authors:  A L Wit; B F Hoffman; M R Rosen
Journal:  Am Heart J       Date:  1975-12       Impact factor: 4.749

2.  Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration.

Authors:  R G Shanks; S G Carruthers; J G Kelly; D G McDevitt
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

3.  The electrophysiology of propranolol in man.

Authors:  S F Seides; M E Josephson; W P Batsford; G M Weisfogel; S H Lau; A N Damato
Journal:  Am Heart J       Date:  1974-12       Impact factor: 4.749

4.  Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man. Presentation of data and critical review of the literature.

Authors:  H C Strauss; A L Saroff; J T Bigger; E G Giardina
Journal:  Circulation       Date:  1973-01       Impact factor: 29.690

5.  Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.

Authors:  B Ablad; E Carlsson; L Ek
Journal:  Life Sci I       Date:  1973-02-01

6.  The electrophysiological evaluation of intravenous acebutolol, a beta-blocking drug.

Authors:  P K Marrott; M S Ruttley; P M Jenkins; J R Muir
Journal:  Eur J Cardiol       Date:  1977-10

7.  Action of propranolol on the atrioventricular node and on its response to adrenaline and isoprenaline.

Authors:  E Kabela; R Méndez
Journal:  Br J Pharmacol Chemother       Date:  1966-02

8.  Electrophysiologic effects of tolamolol on atrioventricular conduction in man.

Authors:  J N Ruskin; A R Caracta; M Akhtar; W P Batsford; A N Damato
Journal:  Am Heart J       Date:  1975-12       Impact factor: 4.749

9.  Plasma levels and electrophysiological effects of acebutolol (M & B 17.803) in the dog heart in situ.

Authors:  J P Amlie; S Lessum; R F Collins; K Landmark
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-03

10.  [The effects of tolamolol on excito-conduction in men (author's transl)].

Authors:  P Alboni; C Malacarne; A M Tomasi; A Masoni
Journal:  G Ital Cardiol       Date:  1977
View more
  3 in total

1.  The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.

Authors:  D L Johnston; D E Manyari; W J Kostuk
Journal:  Can Med Assoc J       Date:  1984-06-01       Impact factor: 8.262

2.  Electrophysiologic effects of intravenous xamoterol in patients with sinus node dysfunction.

Authors:  M de Marneffe; P Waterschoot; A Bernard; P Dubois; F Boujelben; I Liebens; M Englert
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

3.  The electrophysiological effects of intravenous xamoterol in man.

Authors:  R J Bowes; P C Gautam; D R Graham; A Harley
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.